Human medicinal products
SPC PL
Veterinary medicinal
products
SPC PL
Herbal medicinal products
SPC PL
Name of the medicinal
product
A B C D E F G
H I J K L M N
O P Q R S T U
V W X Y Z Å Ä Ö
Name of the medicinal
product

Marketing authorisation
holder

Marketing authorisation
number

ATC Code Codes

Free text search

Active agent

Pharmaceutical form

Adverse effect

Therapeutic indication

Contraindication

Insert text in the fields in Finnish


Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.


Summaries of Product Characteristics 301 - 315 of 315
Previous 30    |  1  2  3  4  5  6  7  8  9  10  11   
Package
leaflet
Status for
supply
Name of the medicinal product

PL

Resepti

Dutasteride Ratiopharm 0.5 mg kapseli, pehmeä SPC 2021-11-01

PL

Resepti

Dutasteride-Tamsulosin Orion 0,5 mg - 0,4 mg kapseli, kova SPC 2022-04-25

PL

Resepti

Dutasteride-Tamsulosinhydrochlorid Accord 0.5 mg_0.4 mg kapseli, kova SPC 2020-01-22

PL

Resepti

Dutasteride-Tamsulosinhydrochlorid ratiopharm 0.5 mg-0.4 mg kapseli, kova SPC 2020 -01-16

PL

Resepti

Dutasteride-Tamsulosinhydrochlorid Stada 0.5 mg-0.4 mg kapseli, kova SPC 2024-02-05

PL

Resepti

Dutasteride-Tamsulosinhydrochloride Sandoz 0.5 mg-0.4 mg kapseli, kova SPC 2020-06-22

PL

Resepti

Dutasteride-Tamsulosinhydrochloride Viatris 0,5 mg-0,4 mg kapseli, kova SPC 2023-02-22

PL

Resepti

Dutester 0.5 mg kapseli, pehmeä SPC 2021-08-06

European Medicines Agency's website:
Duzallo - EMA: EPAR PI
Finnish Swedish

PL

Resepti/itsehoito

Dymista 125 mikrog + 50 mikrog - annos nenäsumute, suspensio SPC 2022-06-22

European Medicines Agency's website:
Dynastat - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Dysport 300 U injektiokuiva-aine, liuosta varten SPC 2022-06-03

PL

Resepti

Dysport 500 U injektiokuiva-aine, liuosta varten SPC 2022-06-03

PL

Resepti

Dyvixarez 0.5 mg - 0.4 mg kapseli, kova SPC 2019-12-18

European Medicines Agency's website:
Dzuveo - EMA: EPAR PI
Finnish Swedish

Previous 30    |  1  2  3  4  5  6  7  8  9  10  11